Lecanemab: FDA Approved for Early Alzheimer's Disease

On July 06, 2023: FDA announced the approval of Leqembi (Lecanemab) for adult patients with early Alzheimer’s Disease or mild cognitive impairment.
Psychiatry Education Forum Academy's Updates have summarized this medication in the following sections:
1. Indications
2. Mechanism
3. Aducanumab versus Lecanemab
4. How to Dose?
5. Adverse Reactions
6. Medicare Coverage
Read details: psychiatryeducationforum.com/...